These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30879123)

  • 1. Grade 3 anaphylactic shock after administration of [
    Skanjeti A; Darcissac C; Jaulent C; Nicolas J; Hallouard F; Morelec I; Fraysse M; Tordo J; Giammarile F; Bolze PA; Dhomps A
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1214-1215. PubMed ID: 30879123
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergy to technetium-labelled nanocolloidal albumin for sentinel node identification.
    Chicken DW; Mansouri R; Ell PJ; Keshtgar MR
    Ann R Coll Surg Engl; 2007 Mar; 89(2):W12-3. PubMed ID: 17346392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc Nanocoll: a radiopharmaceutical for sentinel node localisation in breast cancer--in vitro and in vivo results.
    Gommans GM; Gommans E; van der Zant FM; Teule GJ; van der Schors TG; de Waard JW
    Appl Radiat Isot; 2009 Sep; 67(9):1550-8. PubMed ID: 19328701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Notification of an adverse effect to human albumin (⁹⁹m)Tc-nanocolloid].
    Cotrina-Monroy A; Perez-Iruela JA; Lopez-López A; De Juan R; Rodríguez-Torras ML; Gómez Embuena A
    Rev Esp Med Nucl; 2010; 29(6):308-9. PubMed ID: 20880609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-Year experience regarding the reliability and morbidity of radio guided lymph node biopsy in penile cancer patients and the associated radiation exposure of medical staff in this procedure.
    Lützen U; Naumann CM; Dischinger J; Marx M; Baumann R; Zhao Y; Jüptner M; Osmonov D; Bothe K; Jünemann KP; Zuhayra M
    BMC Urol; 2016 Aug; 16(1):47. PubMed ID: 27485215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer.
    Albo D; Wayne JD; Hunt KK; Rahlfs TF; Singletary SE; Ames FC; Feig BW; Ross MI; Kuerer HM
    Am J Surg; 2001 Oct; 182(4):393-8. PubMed ID: 11720678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of previous surgery on sentinel lymph node mapping: Hybrid SPECT/CT before and after a unilateral diagnostic breast excision.
    Zetterlund L; Gabrielson S; Axelsson R; de Boniface J; Frisell J; Olsson A; Celebioglu F
    Breast; 2016 Dec; 30():32-38. PubMed ID: 27597384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodology of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast.
    Bourgeois P; Leduc O; Belgrado JP; Leduc A
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):831-2; author reply 832-3. PubMed ID: 12029559
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer.
    Kim R; Osaki A; Kojima J; Toge T
    Int J Oncol; 2001 Nov; 19(5):991-6. PubMed ID: 11604999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioguided excision of the nonpalpable breast cancer and simultaneous sentinel lymphnode biopsy using a single radiopharmaceutical: an original approach to accurate administration of the blue dye.
    Zgajnar J; Besic N; Frković-Grazio S; Hocevar M; Vidergar B; Rener M; Lindtner J
    J Surg Oncol; 2003 May; 83(1):48-50. PubMed ID: 12722097
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.
    Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
    Clin Nucl Med; 2001 Apr; 26(4):293-8. PubMed ID: 11290886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of increased (99m)Tc/(99)Tc ratios on count rates in sentinel node procedures: a randomised study.
    Gommans GM; van der Zant FM; van der Schors TG; van Dongen A; Teule GJ; Clarijs WW; Langenhorst BL; de Waard JW
    Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1231-5. PubMed ID: 12827312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
    Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
    Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiation exposure of surgical staff during sentinel node surgery. Is there a risk for the surgeon and his team?].
    Bailly M; Zinsius A; Maia S; Santiago Ribeiro MJ
    Gynecol Obstet Fertil; 2014 May; 42(5):296-300. PubMed ID: 24533993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Tanis PJ; Nieweg OE; Valdés Olmos RA; Hoefnagel CA
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):436-7; author reply 437-8. PubMed ID: 12002722
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intraoperative radiolocalization of intraductal breast carcinoma: sentinel lymph node evaluation].
    Buonomo O; Granai AV; Piccirillo R; Felici A; Muzi F; Cossu E; Marino B; Cipriani C; Roselli M; Simonetti G; Mineo TC
    Tumori; 2003; 89(4 Suppl):177-8. PubMed ID: 12903584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False positive of intramammary sentinel lymph node in lymphoscintigraphy.
    Lanchas Alfonso I; Miguel Martínez MB; García Higuera MI; Montero Ruiz JB; Aragón Martinez J; Duque Gallo JJ
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):161-2. PubMed ID: 21944192
    [No Abstract]   [Full Text] [Related]  

  • 19. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
    World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.